CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-08 | LANGER DENNIS Director | Grant or award · Stock Option | +67,000 | 67,000 | ||
| 2021-09-20 | Sidhu Roger See Remarks | Grant or award · Stock Option | +161,300 | 161,300 | ||
| 2021-09-20 | Sidhu Roger See Remarks | Grant or award · Restricted Stock Unit | +80,650 | 80,650 | ||
| 2021-07-15 | Sial Jay See Remarks | Grant or award · Stock Option | +71,000 | 71,000 | ||
| 2021-07-15 | Sial Jay See Remarks | Grant or award · Restricted Stock Unit | +35,700 | 35,700 | ||
| 2021-07-14 | DENNY GEORGE P III 10% owner | Purchase | +1 | $11.99 | $12 | 3 |
| 2021-07-09 | DENNY GEORGE P III 10% owner | Purchase | +1 | $14.11 | $14 | 2 |
| 2021-07-08 | DENNY GEORGE P III 10% owner | Purchase | +1 | $14.35 | $14 | 1 |
| 2021-07-06 | DENNY GEORGE P III 10% owner | Sale | −75,000 | $16.06 | $1.2M | 4,775,117 |
| 2021-06-28 | DAmour Kevin See Remarks | Grant or award · Stock Option | +140,580 | 140,580 | ||
| 2021-06-28 | DAmour Kevin See Remarks | Grant or award · Restricted Stock Unit | +70,290 | 70,290 | ||
| 2021-06-21 | Gurrola Sandra M Vice President of Finance | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2021-06-17 | Cherington Charles Director | Sale | −198,000 | $15.74 | $3.1M | 5,896,101 |
| 2021-06-17 | Cherington Charles Director | Sale | −2,000 | $16.30 | $33K | 5,894,101 |
| 2021-06-16 | Cherington Charles Director | Sale | −200,000 | $15.73 | $3.1M | 6,094,101 |
| 2021-06-01 | Cherington Charles Director | Other acquisition | +92 | 5,894,193 | ||
| 2021-04-16 | Federoff Howard J. See Remarks | Grant or award · Stock Option | +2,627,915 | 2,627,915 | ||
| 2021-04-16 | Federoff Howard J. See Remarks | Grant or award · Stock Option | +597,253 | 597,253 | ||
| 2021-03-24 | Wolff Allen Former Director and CEO | Shares withheld for taxes | −9,944 | $2.67 | $27K | 128,520 |
| 2021-03-24 | Gurrola Sandra M Former SVP of Finance | Shares withheld for taxes | −6,094 | $2.67 | $16K | 21,617 |
Page 7 of 33 · 657 trades